FDA clears Werfen’s ROTEM sigma complete cartridge for trauma use

Werfen received FDA 510(k) clearance for the ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma in the United States.

Werfen has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ROTEM sigma complete cartridge to assess peri-operative hemorrhage and/or thrombosis in trauma, according to an announcement.

The new indication extends the use of the ROTEM sigma viscoelastic testing system beyond cardiovascular surgery and liver transplantation, enabling bleeding management in the trauma setting within the United States.

ROTEM sigma is a fully automated viscoelastic testing system that delivers real-time assessment of clot initiation, clot firmness, and clot stability at the point of care. By providing timely information about a patient's coagulation status, the system supports individualized treatment strategies during critical bleeding events. ROTEM sigma results should be interpreted together with the patient's clinical condition and other laboratory tests.

Additional key features:

  • Fully automated cartridge-based system
  • Closed-tube direct sampling
  • Minimizes manual handling steps
  • Reduces operator-dependent variability
  • Automated assay initiation
  • Integrated quality control
  • Continuous internal system monitoring
  • Intuitive touchscreen operation
  • Room-temperature cartridge storage
  • Real-time visibility into coagulation dynamics

The full indications for use can be found on Werfen’s website.

About the Author

 LABline
Sign up for our eNewsletters
Get the latest news and updates